VivoSeq
Other

Peptides

0

Pipeline Programs↗

1

Active Trials↗

1

Companies Involved↗

Peptides is an early-stage landscape with 0 programs across 1 company. The most active players are ASIT Biotech S.A..

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

A

ASIT Biotech S.A.

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

15

clinical trials

Completed12 · 80%
Unknown status2 · 13%
Recruiting1 · 7%

Clinical Trials

Trial Activity

15 trials

Plantar Fascitiis: Comparison of ESWT and Collagen Hydrolyzed Peptides
Recruiting·AAzienda Ospedaliero-Universitaria Consorziale Policlinico di Bari·Phase 1·NCT06138236·84 enrolled
Race, Natriuretic Peptides and Physiological Perturbations
Completed·UUniversity of Alabama at Birmingham·Phase 2·NCT03070184·80 enrolled
Safety and Clinical Tolerability of hdmASIT+TM Peptides Administered in HDM-induced Allergic Patients
Completed·AASIT Biotech S.A.·Phase 2·NCT03094845·36 enrolled
Neuropeptides in Human Reproduction
Completed·MMassachusetts General Hospital·Phase 1·NCT01952782·61 enrolled
Safety Study of Cancer Specific Epitope Peptides Cocktail for Cervical, GI, and Lung Tumors
Completed·KKyushu University·Phase 1·NCT00676949·18 enrolled
Diurnal Variation of Exogenous Peptides (GH Puls/Jurgita I)
Completed·—·Phase 2·NCT01090778·8 enrolled
Study of Multiplexed Heptapeptides for Detection of Neoplasia in the Esophagus
Completed·UUniversity of Michigan·Phase 1·NCT03589443·27 enrolled
Brain Natriuretic Peptide Effects on Appetite Regulating Hormones and Endothelial Derived Peptides
Completed·MMedical University of Vienna·N/A·NCT01375153·10 enrolled
CpG 7909/Montanide ISA 720 With or Without Cyclophosphamide in Combination Either With NY-ESO-1-derived Peptides or the NY-ESO-1 Protein for NY-ESO-1-expressing Tumors
Completed·HHassane M. Zarour, MD·Phase 1·NCT00819806·21 enrolled
Diurnal Variation of Exogenous Peptides (Endogenous Insulin Jurgita II)
Completed·—·Phase 2·NCT01510093·10 enrolled
Neuropeptides in the Humane Intra- og Extracerebral Circulation.
Completed·DDanish Headache Center·N/A·NCT00399633·16 enrolled
Multiple Class I Peptides & Montanide ISA 51 VG w Escalating Doses of Anti-PD-1 ab BMS936558
Completed·HH. Lee Moffitt Cancer Center and Research Institute·Phase 1·NCT01176461·127 enrolled
Safety of Intradermal Versus Intramuscular Administration of HIV Lipopeptides in HIV Uninfected Adult Volunteers
Completed·FFrench National Agency for Research on AIDS and Viral Hepatitis·Phase 1·NCT00121121·70 enrolled
Pharmacodynamic Effects of Sacubitril/Valsartan on Natriuretic Peptides, Angiotensin and Neprilysin
Unknown status·OOslo University Hospital·Phase 4·NCT03553303·40 enrolled
Vasoactive Peptides in Portal Pressure
Unknown status·BBayside Health·N/A·NCT00163982

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)